ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
83,794.53
-0.40%
S&P 500
5,662.89
0.00%
Dow Jones
41,953.32
0.00%
US Dollar vs Yen
148.818
0.14%
Brent Oil
71.455
-0.57%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Ascendis Pharma AS (ASND)

  7. Ascendis Pharma AS (ASND) ニュース

ASND

Ascendis Pharma AS (ASND)

Ascendis Pharma AS
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:ASND
日付受信時刻ニュースソース見出しコード企業名
2025/03/2105 : 17Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASNDAscendis Pharma AS
2025/03/1305 : 48Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASNDAscendis Pharma AS
2025/03/0807 : 03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ASNDAscendis Pharma AS
2025/03/0604 : 31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ASNDAscendis Pharma AS
2025/03/0510 : 38Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ASNDAscendis Pharma AS
2025/03/0510 : 32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ASNDAscendis Pharma AS
2025/03/0510 : 27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ASNDAscendis Pharma AS
2025/03/0510 : 22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ASNDAscendis Pharma AS
2025/03/0510 : 15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ASNDAscendis Pharma AS
2025/03/0510 : 12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ASNDAscendis Pharma AS
2025/03/0510 : 04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ASNDAscendis Pharma AS
2025/03/0510 : 00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ASNDAscendis Pharma AS
2025/03/0509 : 55Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ASNDAscendis Pharma AS
2025/03/0509 : 50Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ASNDAscendis Pharma AS
2025/03/0509 : 45Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ASNDAscendis Pharma AS
2025/03/0509 : 40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ASNDAscendis Pharma AS
2025/02/2806 : 02Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ASNDAscendis Pharma AS
2025/02/2506 : 01GlobeNewswire Inc.Ascendis Pharma to Participate in the TD Cowen 45th Annual Health Care ConferenceNASDAQ:ASNDAscendis Pharma AS
2025/02/2120 : 11Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ASNDAscendis Pharma AS
2025/02/2106 : 15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ASNDAscendis Pharma AS
2025/02/2007 : 06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ASNDAscendis Pharma AS
2025/02/2006 : 56Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ASNDAscendis Pharma AS
2025/02/1907 : 30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ASNDAscendis Pharma AS
2025/02/1306 : 12Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASNDAscendis Pharma AS
2025/02/1306 : 07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASNDAscendis Pharma AS
2025/02/1306 : 05GlobeNewswire Inc.Ascendis Pharma A/S Announces Share Repurchase Program & Net Settlement of Certain RSUsNASDAQ:ASNDAscendis Pharma AS
2025/02/1306 : 01GlobeNewswire Inc.Ascendis Pharma Reports Fourth Quarter and Full Year 2024 Financial ResultsNASDAQ:ASNDAscendis Pharma AS
2025/02/1305 : 24Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASNDAscendis Pharma AS
2025/02/0606 : 01GlobeNewswire Inc.Ascendis Pharma to Report Full Year 2024 Financial Results and Provide Business Update on February 12, 2025NASDAQ:ASNDAscendis Pharma AS
2025/01/1606 : 39Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASNDAscendis Pharma AS
 Showing the most relevant articles for your search:NASDAQ:ASND

最近閲覧した銘柄

USOTC
GSCE
Goldman Sachs (PK)
NASDAQ
ABNWFXX
Jpmorgan Chase Financial...
NASDAQ
ABKDLXX
Morgan Stanley Finance L...
NASDAQ
ABLTTXX
Bofa Finance Llc Issuer ...
NASDAQ
ABNABXX
Bank of Montreal Capped ...
FX
GBPKYD
Sterling vs KYD
FX
XOFNAD
XOF vs NAD
BIT
LVMH
Lvmh Moet Hennessy Vuitton
NYSE
NATL
National Interstate
BOV
BBDC3R
BRADESCO ON
BOV
BPAN4Q
BANCO PAN PN
TSXV
FREE
Freedom Energy
NASDAQ
ABMGFXX
Jpmorgan Chase Bank Na P...
NASDAQ
ABMLHXX
Jpmorgan Chase Bank Na P...
NASDAQ
ABNNBXX
Citigroup Global Markets...
TSX
RBNK
RBC Canadian Bank Yield ...
Delayed Upgrade Clock
ADVFN Logo
日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有

広告を削除する

サインアップして広告なしのエクスペリエンスを体験してください

広告なし

今すぐ試してください

広告を残す